Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
In a new study just published in the Journal of Neuroscience, scientists from Australia, the United States (Oregon), and the United Kingdom showed in laboratory animal tests that oral intake of this compound significantly extended the lifespan and improved the locomotor function of transgenic mice that are genetically engineered to develop this debilitating and terminal disease.
In humans, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months. Researchers in the Linus Pauling Institute at Oregon State University say this approach has the potential to change that, and may have value against Parkinson’s disease as well.
“We believe that with further improvements, and following necessary human clinical trials for safety and efficacy, this could provide a valuable new therapy for ALS and perhaps Parkinson’s disease,” said Joseph Beckman, a distinguished professor of biochemistry and biophysics in the OSU College of Science.
“I’m very optimistic,” said Beckman, who received the 2012 Discovery Award from the OHSU Medical Research Foundation as the leading medical researcher in Oregon.
Read more . . .
The Latest on: Therapy for Lou Gehrig’s disease
[google_news title=”” keyword=”Therapy for Lou Gehrig’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Therapy for Lou Gehrig’s disease
- Scientists report that new gene therapy slows down amyotrophic lateral sclerosis disease progressionon April 26, 2024 at 9:09 am
There has been a breakthrough in the research on the disease amyotrophic lateral sclerosis (ALS). Scientists at Umeå University report that the disease progression in a patient with a particularly ...
- Section III softball, baseball teams to take part in 15th annual Strike out Lou Gehrig’s Disease Classicon April 25, 2024 at 1:33 pm
Section III will have nine softball and 16 baseball teams participating in the 15th annual Strike out Lou Gehrig’s Disease Classic. Games are scheduled to start on Saturday.
- East High Baseball honors Joe LaPietra at the Strike Out Lou Gehrig's Disease Classicon April 21, 2024 at 2:27 am
East High baseball improved to 8-0 with a 13-2 win over Bishop Kearney/Chesterton.The Eagles, though, won before they stepped onto the fie ...
- Symptoms of ALS or Lou Gehrig's Diseaseon April 14, 2024 at 5:00 pm
They include: Physical therapy. It focuses mostly on larger ... It's also called Lou Gehrig's disease. It often starts in your hands, feet, arms, or legs. You might notice trouble walking or ...
- In a rare move, maker of failed ALS drug removes it from the marketon April 4, 2024 at 6:43 am
About 6,000 people a year in the United States are diagnosed with ALS, often called Lou Gehrig’s disease, which kills by progressively shutting down the body’s ability to move, speak and ...
via Bing News
